Agnese Restuccia, PhD

Gilead Sciences Europe Ltd, United Kingdom

Disclosure(s): Gilead Sciences: Stocks/Bonds (Private Company)

Poster(s):

• (P-1973) Characteristics, Clinical Management, and Outcomes of Immunocompromised Patients Diagnosed with COVID-19 in the Outpatient Setting in France
  Saturday, October 19, 2024

  12:15 PM – 1:30 PM US PT